Hide Board Information

Show Board Information

Ultrashort Russell Midcap Growth SDK

Board Mod: Add me as mod

Asst Mods:

Last Post: 10/29/2012 7:30:55 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 2

1. SDK Company Profile

    

2. SDK Time & Sales

    

3. SDK Recent News

    

4. SDK Filings

    

5. SDK Financials

    

6. SDK Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

Be the first to post on Ultrashort Russell Midcap Growth SDK

Recent Articles

• Cryptocurrency Performance: Insights on Recent Market Movements
• MegazoneCloud's Ambitious U.S. Revenue Growth Strategy Unveiled
• Unleashing Excitement: BC.GAME's Upcoming Night of Fun
• HKEX Unveils Innovative Tech 100 Index to Boost Investments
• InnoCare Pharma Unveils Promising BCL2 Inhibitor Data at ASH
• Rio2 Limited Upsizes Bought Deal Financing to C$166 Million
• Rio2 Expands Financing Deal to C$166 Million Amid Demand
• Understanding the Recent Class Action Against Gauzy Ltd. (GAUZ)
• Gauzy Ltd. Faces Class Action as Financial Trouble Looms
• Lead Your Claim: aTyr Pharma Investors Have Options
• MetaComp Secures $22 Million to Fortify Cross-Border Payments
• Enhanced Quality of Life and Survival Outcomes for Ivonescimab
• Cathie Wood's Ark Invest Shifts Focus to Baidu from Tesla
• Nidec Corporation Investors: Key Updates and Actions to Take
• Investors Presented with a Class Action Opportunity Against ARE
• Hong Kong Unites After Fire, Showcases Resilience and Hope
• Examining the Worth of Alexander & Baldwin's Shareholder Deal
• Innovative Wellness Gifts from SKG for a Healthier Holiday Season
• TDECU Welcomes New Strategic Leaders to Board for Growth
• EnWave Corporation's Upcoming Q4 2025 Financial Report Plans
• Cygnus Metals Limited Issues Performance Rights to Employees
• Netcapital Inc. Implements New Incentive Program for Growth
• Insights on Alvotech's Class Action Investigation by Rosen Law
• Monument Mining's AGM: Key Highlights and Future Directions
• RetinalGenix Technologies Welcomes M. Cory Zwerling as New CFO
• ALT5 Sigma Corp Faces Investigation Over Securities Concerns
• Legal Alert: DeFi Technologies Class Action Lawsuit Update
• Market Updates: Key Stocks Drawing Investor Interest Today
• Hormel Foods Corporation Investors: Taking Action on Legal Rights
• Investigation on Nidec Corporation: Investors Aware of Claims
• Brookfield Corporation Unveils C$1 Billion Medium-Term Notes
• Marquis Software Faces Data Breach Concerns Affecting Customers
• California Consumers Face $59 Billion Gas Overcharge Crisis
• Cali-Power Football Team Triumphs in Court Over Title Rights
• Ascentage Pharma Showcases Long-Term Efficacy Data for Olverembatinib
• Promising Results from Phase III POLARIS-1 Study of Olverembatinib
• Promising New Data on Olverembatinib for CML Treatment
• Promising Update on Olverembatinib for CML-CP Patients
• Olverembatinib's Significant Long-Term Impact for CML Patients
• CoreWeave, Inc.: Investigating Claims and Market Impact
• Hong Kong Rallies Together to Rebuild After Tragic Fire
• RetinalGenix Welcomes M. Cory Zwerling as New CFO and Interim COO
• Star Group, L.P. Sees Growth in 2025 Financial Results
• Star Group, L.P. Achieves Revenue Growth in Fiscal 2025
• Shaquille O'Neal's Innovative Journey from Basketball to Tech
• BioArctic's Leqembi Listed as Innovative Drug in China
• Innovent Biologics Delivers Breakthrough in Psoriasis Treatment
• Vermilion Energy Expands Financial Strategy Through Share Sales
• Morgan Dudley Joins Stargaze as Creative Advisor for New Era
• Understanding the Securities Class Action for Telix Pharmaceuticals